COVID-19 vaccine study for healthy adults aged 18 to 64
Part of Infections, Lungs & breathing clinical trials.
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are generally healthy and do not have medical conditions that make severe COVID-19 more likely.
- You have not tested positive for COVID-19 in the past 6 months (180 days).
- You have not recently received a vaccine and will not get another COVID-19 vaccine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a COVID-19 vaccine in children and adults. It may help protect against COVID-19.
This study tests a new COVID-19 vaccine (called BMI2012) in healthy adults. It aims to see if the vaccine is safe and triggers a good immune response against new variants of the virus. If you qualify, you'd receive the vaccine and be monitored over time.
This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.
This trial tests two new experimental vaccines to see if they are safe and how the body responds to them. It is only for healthy adults, so if you are generally well, you might be able to take part.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
Hear when a new COVID-19 Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.